Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemia - Rogers, Kerry A.; Thompson, Philip A.; Allan, John N.; Coleman, Morton; Sharman, Jeff P.; Cheson, Bruce D.; Jones, Daniel; Izumi, Raquel; Frigault, Melanie M.; Quah, Cheng; Raman, Rakesh K.; Patel, Priti; et al. (Haematologica (Roma), 2021)